melanoma

2:31
New models for patient care: advanced pharmacy practitioners
Dharmisha Chauhan
1:21
Treatment options for mucosal melanoma patients
Marcus Butler
3:35
KEYNOTE-006: the efficacy of ipilimumab after pembrolizumab in patients with advanced melanoma
Georgina Long
1:36
Preventing melanoma through public health education
Georgina Long
3:01
Oncolytic virus therapy in the treatment of melanoma
Kevin Harrington
2:58
Role of BRAF mutation in the treatment for melanoma
Dirk Schadendorf
5:40
Immunotherapy and targeted therapies for melanoma
Caroline Robert
2:12
Current clinical perspectives on targeted therapy and immunotherapy for melanoma
Caroline Robert
5:00
Clinical developments in the treatment for melanoma
Axel Hauschild
4:25
Aggressive care at the end-of-life for younger cancer patients: ASCO’s Choosing Wisely campaign
Ronald Chen
4:28
Global differences in cancer drug prices: a comparative analysis
Daniel Goldstein
6:11
Targeted therapy for advanced solid tumors based on molecular profiles: early results from MyPathway
John Hainsworth
1:25
Targeting RAS oncogenes in patients with NRAS-mutated melanoma
Grant McArthur
3:08
OS rates and prognostic categories for BRAF-mutated melanoma when treated with combination therapy
Grant McArthur
2:01
CheckMate 172 trial of nivolumab for advanced melanoma: preliminary results
Paolo Ascierto
2:15
ASCO 2016 highlights for immunotherapy
Hendrik-Tobias Arkenau
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals